| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.009 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.009 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |